Highlights
- Market Cap
- $2.74B
- Enterprise Value
- $3.29B
- EPS (TTM)
- $2.55
- PE Ratio
- 29.59
- PEG Ratio
- 0.07
- Total Revenue (TTM)
- $3.81B
- Gross Profit (TTM)
- $961.20M
- EBITDA (TTM)
- $336.10M
- Year Range
- $34.88 - $84.46
- Target Price
- $100.00
- ROA (TTM)
- 2.45%
- ROE (TTM)
- 8.60%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Diebold Nixdorf, Incorporated, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
Diebold Nixdorf, Incorporated (DBD) has returned 11.12% so far this year and 72.55% over the past 12 months.
Diebold Nixdorf, Incorporated
- 1D
- 2.50%
- 1M
- -5.70%
- YTD
- 11.12%
- 6M
- 32.28%
- 1Y
- 72.55%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Aug 15, 2023, DBD's average daily return is +0.22%, while the average monthly return is +4.56%. At this rate, your investment would double in approximately 1.3 years.
Historically, 72% of months were positive and 28% were negative. The best month was May 2024 with a return of +38.2%, while the worst month was Aug 2023 at -17.2%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 2 months.
On a daily basis, DBD closed higher 53% of trading days. The best single day was Nov 5, 2025 with a return of +12.5%, while the worst single day was Nov 7, 2024 at -13.7%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 1.65% | 15.93% | -5.70% | 11.12% | |||||||||
| 2025 | 0.58% | 2.17% | -1.15% | 1.40% | 8.66% | 15.01% | 1.61% | 8.56% | -6.68% | 3.72% | 9.08% | 5.22% | 57.74% |
| 2024 | 5.01% | 8.42% | 4.49% | -8.07% | 38.19% | -12.05% | 13.18% | 2.92% | -0.36% | 3.63% | -0.13% | -6.88% | 48.67% |
| 2023 | -17.16% | 6.34% | 0.21% | 35.30% | 12.73% | 34.65% |
Benchmark Metrics
Diebold Nixdorf, Incorporated has an annualized alpha of 46.76%, beta of 1.12, and R² of 0.18 versus S&P 500 Index. Calculated based on daily prices since August 16, 2023.
- This stock captured 195.61% of S&P 500 Index gains and tended to rise during its downturns (downside capture of -45.54%) — a profile typical of hedging or uncorrelated assets.
- R² of 0.18 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 46.76%
- Beta
- 1.12
- R²
- 0.18
- Upside Capture
- 195.61%
- Downside Capture
- -45.54%
Return for Risk
Risk / Return Rank
DBD ranks 90 for risk / return — in the top 90% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Diebold Nixdorf, Incorporated (DBD) and compare them to a chosen benchmark (S&P 500 Index).
| DBD | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.99 | 0.90 | +1.09 |
Sortino ratioReturn per unit of downside risk | 2.65 | 1.39 | +1.27 |
Omega ratioGain probability vs. loss probability | 1.37 | 1.21 | +0.16 |
Calmar ratioReturn relative to maximum drawdown | 4.26 | 1.40 | +2.86 |
Martin ratioReturn relative to average drawdown | 13.19 | 6.61 | +6.59 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore DBD risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the Diebold Nixdorf, Incorporated. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Diebold Nixdorf, Incorporated was 25.76%, occurring on Apr 8, 2025. Recovery took 41 trading sessions.
The current Diebold Nixdorf, Incorporated drawdown is 9.16%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -25.76% | Nov 7, 2024 | 103 | Apr 8, 2025 | 41 | Jun 6, 2025 | 144 |
| -20.65% | May 28, 2024 | 20 | Jun 25, 2024 | 14 | Jul 16, 2024 | 34 |
| -20.56% | Aug 16, 2023 | 16 | Sep 7, 2023 | 47 | Nov 13, 2023 | 63 |
| -19.93% | Jul 17, 2024 | 14 | Aug 5, 2024 | 19 | Aug 30, 2024 | 33 |
| -13.97% | Feb 27, 2026 | 16 | Mar 20, 2026 | — | — | — |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Diebold Nixdorf, Incorporated over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Diebold Nixdorf, Incorporated is priced in the market compared to other companies in the Software - Application industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for DBD, comparing it with other companies in the Software - Application industry. Currently, DBD has a P/E ratio of 29.6. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for DBD compared to other companies in the Software - Application industry. DBD currently has a PEG ratio of 0.1. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for DBD relative to other companies in the Software - Application industry. Currently, DBD has a P/S ratio of 0.7. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for DBD in comparison with other companies in the Software - Application industry. Currently, DBD has a P/B value of 2.5. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |